Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical expression of MGMT in Gliomas.

Cellular and molecular biology (Noisy-le-Grand, France) - 31 Jul 2020

Jalal Jalal Ali

Abstract excerpt

Glioma is one of the main tumors of the central nervous system occurring in the spinal cord or brain, and is the origin of glioma tumors. The most common site of glioma is the brain. Glioma accounts for 30% of all central nervous system tumors and 80% of malignant brain tumors. O6-methylguanine-DNA methyltransferase (MGMT) gene mutations have been identified in many human cancers including gliomas. This study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Brain Neoplasms
Share to DNA Modification Methylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Glioma

Share to Neoplasm Grading

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 33040807

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical expression of MGMT in Gliomas.PMID 33040807Read ↗

Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cellsSemantic proximity Read ↗

Diagnosis and management of multiple high-grade gliomas: a retrospective studySemantic proximity Read ↗

Applicable advances in the molecular pathology of glioblastoma.Semantic proximity Read ↗

Updates in prognostic markers for gliomasSemantic proximity Read ↗

Molecular Neuropathology of GliomasSemantic proximity Read ↗

O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma ChemotherapySemantic proximity Read ↗

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational StudySemantic proximity Read ↗

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.Semantic proximity Read ↗

Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.Semantic proximity Read ↗

MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors.Semantic proximity Read ↗

Immunohistochemical characterisation and histopathology of astrocytic neoplasms at a tertiary Nigerian hospital.Semantic proximity Read ↗

Overview and recent advances in neuropathology. Part 1: Central nervous system tumours.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.